These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 20684143

  • 1. Long-term safety and efficacy of etanercept in patients with psoriasis: an open-label study.
    Leonardi C, Strober B, Gottlieb AB, Elewski BE, Ortonne JP, van de Kerkhof P, Chiou CF, Dunn M, Jahreis A.
    J Drugs Dermatol; 2010 Aug; 9(8):928-37. PubMed ID: 20684143
    [Abstract] [Full Text] [Related]

  • 2. Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
    Tyring S, Gordon KB, Poulin Y, Langley RG, Gottlieb AB, Dunn M, Jahreis A.
    Arch Dermatol; 2007 Jun; 143(6):719-26. PubMed ID: 17576937
    [Abstract] [Full Text] [Related]

  • 3. Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension.
    van de Kerkhof PC, Segaert S, Lahfa M, Luger TA, Karolyi Z, Kaszuba A, Leigheb G, Camacho FM, Forsea D, Zang C, Boussuge MP, Paolozzi L, Wajdula J.
    Br J Dermatol; 2008 Nov; 159(5):1177-85. PubMed ID: 18673365
    [Abstract] [Full Text] [Related]

  • 4. A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction.
    Papp KA, Tyring S, Lahfa M, Prinz J, Griffiths CE, Nakanishi AM, Zitnik R, van de Kerkhof PC, Melvin L, Etanercept Psoriasis Study Group.
    Br J Dermatol; 2005 Jun; 152(6):1304-12. PubMed ID: 15948997
    [Abstract] [Full Text] [Related]

  • 5. Comparison of clinical and pharmacokinetic profiles of etanercept 25 mg twice weekly and 50 mg once weekly in patients with psoriasis.
    Elewski B, Leonardi C, Gottlieb AB, Strober BE, Simiens MA, Dunn M, Jahreis A.
    Br J Dermatol; 2007 Jan; 156(1):138-42. PubMed ID: 17199580
    [Abstract] [Full Text] [Related]

  • 6. A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasis.
    Moore A, Gordon KB, Kang S, Gottlieb A, Freundlich B, Xia HA, Stevens SR.
    J Am Acad Dermatol; 2007 Apr; 56(4):598-603. PubMed ID: 17113190
    [Abstract] [Full Text] [Related]

  • 7. Once-weekly administration of high-dosage Etanercept in patients with plaque psoriasis: results of a pilot experience (power study).
    Cassano N, Loconsole F, Galluccio A, Miracapillo A, Pezza M, Vena GA.
    Int J Immunopathol Pharmacol; 2006 Apr; 19(1):225-9. PubMed ID: 16569361
    [Abstract] [Full Text] [Related]

  • 8. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
    Kircik LH.
    J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A, Esposito M, Costanzo A, Chimenti S.
    Am J Clin Dermatol; 2009 Aug; 10(5):319-24. PubMed ID: 19658444
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of etanercept in children and adolescents aged > or = 8 years with severe plaque psoriasis.
    Landells I, Paller AS, Pariser D, Kricorian G, Foehl J, Molta C, Freundlich B.
    Eur J Dermatol; 2010 Aug; 20(3):323-8. PubMed ID: 20185386
    [Abstract] [Full Text] [Related]

  • 11. Once-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis.
    Reich K, Segaert S, Van de Kerkhof P, Durian C, Boussuge MP, Paolozzi L, Wajdula J, Boggs R.
    Dermatology; 2009 Aug; 219(3):239-49. PubMed ID: 19752505
    [Abstract] [Full Text] [Related]

  • 12. Two years of experience with etanercept in recalcitrant psoriasis.
    Ahmad K, Rogers S.
    Br J Dermatol; 2007 May; 156(5):1010-4. PubMed ID: 17408393
    [Abstract] [Full Text] [Related]

  • 13. Our experience with etanercept in the treatment of psoriasis.
    Kokelj F, Miertusova Tothova S, Patamia M, Trevisan G.
    Acta Dermatovenerol Croat; 2006 May; 14(4):241-5. PubMed ID: 17311738
    [Abstract] [Full Text] [Related]

  • 14. Etanercept treatment for children and adolescents with plaque psoriasis.
    Paller AS, Siegfried EC, Langley RG, Gottlieb AB, Pariser D, Landells I, Hebert AA, Eichenfield LF, Patel V, Creamer K, Jahreis A, Etanercept Pediatric Psoriasis Study Group.
    N Engl J Med; 2008 Jan 17; 358(3):241-51. PubMed ID: 18199863
    [Abstract] [Full Text] [Related]

  • 15. Long-term etanercept in pediatric patients with plaque psoriasis.
    Paller AS, Siegfried EC, Eichenfield LF, Pariser D, Langley RG, Creamer K, Kricorian G.
    J Am Acad Dermatol; 2010 Nov 17; 63(5):762-8. PubMed ID: 20605256
    [Abstract] [Full Text] [Related]

  • 16. Assessment of the long-term safety and effectiveness of etanercept for the treatment of psoriasis in an adult population.
    Papp KA, Poulin Y, Bissonnette R, Bourcier M, Toth D, Rosoph L, Poulin-Costello M, Setterfield M, Syrotuik J.
    J Am Acad Dermatol; 2012 Feb 17; 66(2):e33-45. PubMed ID: 20850895
    [Abstract] [Full Text] [Related]

  • 17. Intermittent etanercept therapy in pediatric patients with psoriasis.
    Siegfried EC, Eichenfield LF, Paller AS, Pariser D, Creamer K, Kricorian G.
    J Am Acad Dermatol; 2010 Nov 17; 63(5):769-74. PubMed ID: 20833444
    [Abstract] [Full Text] [Related]

  • 18. [Long-term safety and efficacy of etanercept in the treatment of psoriasis].
    Zaragoza V, Pérez A, Sánchez JL, Oliver V, Martínez L, Alegre V.
    Actas Dermosifiliogr; 2010 Nov 17; 101(1):47-53. PubMed ID: 20109392
    [Abstract] [Full Text] [Related]

  • 19. Moderate to severe plaque psoriasis with scalp involvement: a randomized, double-blind, placebo-controlled study of etanercept.
    Bagel J, Lynde C, Tyring S, Kricorian G, Shi Y, Klekotka P.
    J Am Acad Dermatol; 2012 Jul 17; 67(1):86-92. PubMed ID: 22014541
    [Abstract] [Full Text] [Related]

  • 20. Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.
    Krueger GG, Langley RG, Finlay AY, Griffiths CE, Woolley JM, Lalla D, Jahreis A.
    Br J Dermatol; 2005 Dec 17; 153(6):1192-9. PubMed ID: 16307657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.